Type
. [Erythema Nodosum Leprosum: clinical and therapeutic up-date]. Anais Brasileiros de Dermatologia. 2002;77(4):389-407 .
Type
. [Silent neuritis in multibacillary leprosy evaluated through the development of disabilities before, during and after multidrug therapy]. Anais Brasileiros de Dermatologia. 2004;79(2):169-179.
Type
. Sample survey in leprosy-an introductory manual [Internet]. Unpublished. WHO/CDS/LEP 86.1. Geneva: World Health Organization; 1987. Available from: http://apps.who.int/iris/bitstream/10665/58380/1/WHO_CDS_LEP_86.1.pdf
Type
. Developing and testing of the foot care confidence scale. Journal of Nursing Measurement. 2002;10(3):207-18.
Type
. Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice. PLoS neglected tropical diseases [Internet]. 2013;7(8):e2404. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750008/pdf/pntd.0002404.pdf
Type
. Interactions between HIV infection and leprosy: a paradox. The Lancet. 2006;6(6):350-60.
Type
. Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin. The American journal of tropical medicine and hygiene. 2012;86(2):264-7.
Type
. The development of arthritis and antinuclear antibodies correlate with serum 25-hydroxyvitamin D levels in patients with leprosy. Annals of the rheumatic diseases. 2012;.
Type
. [Estimation of the execution of the national strategy of leprosy elimination in the "Hauts Bassins" region in Burkina Faso]. Le Mali medical. 2012;27(1):27-32.
Type
. Oro-facial manifestations of 100 leprosy patients. Medicina oral, patologia oral y cirugia bucal [Internet]. 2012;17(5):e728-32. Available from: http://www.medicinaoral.com/medoralfree01/aop/17718.pdf